Blood transfusion · women undergoing first trimester abortion
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Glaucoma progression at 12 months, measured by additional visual field defects · people with primary open‐angle glaucoma or ocular hypertension
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Difference in mean IOP from baseline at < 6 months · people with primary open‐angle glaucoma or ocular hypertension
1 finding from 1 review
Glaucoma progression at 12 months, defined by anatomic (structural) criteriab · people with primary open‐angle glaucoma or ocular hypertension
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient‐reported outcome at the longest · people with primary open‐angle glaucoma or ocular hypertension
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean change in the number of glaucoma medications at the longest · people with primary open‐angle glaucoma or ocular hypertension
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for extra treatment · people with primary open‐angle glaucoma or ocular hypertension
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of ocular adverse events at the longest · people with primary open‐angle glaucoma or ocular hypertension
1 finding from 1 review
Caesarean section · pregnant women carrying a live fetus at or near term (≥ 36 weeks' gestation).
Amniotic membranes sweeping showed no clear difference in caesarean section compared with vaginal/intracervical prostaglandins (low certainty).
1 finding from 1 review
Spontaneous vaginal birth · pregnant women carrying a live fetus at or near term (≥ 36 weeks' gestation).
Amniotic membranes sweeping showed no clear difference in spontaneous vaginal birth compared with vaginal/intracervical prostaglandins (low certainty).
1 finding from 1 review
Uterine hyperstimulation with/without fetal heart rate (FHR) changes ‐ not reported · pregnant women carrying a live fetus at or near term (≥ 36 weeks' gestation).
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious maternal morbidity or death · pregnant women carrying a live fetus at or near term (≥ 36 weeks' gestation).
Amniotic membranes sweeping showed no clear difference in maternal death or serious maternal morbidity compared with vaginal/intracervical prostaglandins (low certainty).
1 finding from 1 review
Neonatal death or serious neonatal perinatal morbidity · pregnant women carrying a live fetus at or near term (≥ 36 weeks' gestation).
Amniotic membranes sweeping showed no clear difference in neonatal death or serious neonatal perinatal morbidity compared with vaginal/intracervical prostaglandins (low certainty).
1 finding from 1 review
Spontaneous onset of labour · pregnant women carrying a live fetus at or near term (≥ 36 weeks' gestation).
Amniotic membranes sweeping showed no clear difference in spontaneous onset of labour compared with vaginal/intracervical prostaglandins (low certainty).
1 finding from 1 review
Induction of labour · pregnant women carrying a live fetus at or near term (≥ 36 weeks' gestation).
Amniotic membranes sweeping showed no clear difference in induction of labour compared with vaginal/intracervical prostaglandins (low certainty).
1 finding from 1 review
Ulcer healing · patients with Buerger's disease
It is very uncertain whether intravenous prostacyclin analogue changes ulcer healing compared with intravenous prostaglandin analogue (very low certainty).
1 finding from 1 review
Complete relief of pain · patients with Buerger's disease
Intravenous prostacyclin analogue showed no clear difference in complete relief of pain compared with intravenous prostaglandin analogue (low certainty).
1 finding from 1 review
Rate of amputation · patients with Buerger's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Self‐reported potency · post‐prostatectomy erectile dysfunction (short‐term)
It is very uncertain whether scheduled PDE5I changes self‐reported potency compared with scheduled intraurethral prostaglandin E1 (very low certainty).
1 finding from 1 review
Erectile function · post‐prostatectomy erectile dysfunction (short‐term)
It is very uncertain whether scheduled PDE5I changes erectile function compared with scheduled intraurethral prostaglandin E1 (very low certainty).
2 findings from 1 review